Informazione tecnica HSE / 25 ° anno
/ Documenti disponibili:
44.817
/ Documenti scaricati: 32.857.010
/ Documenti scaricati: 32.857.010
Compliance with good manufacturing practice (“GMP”) is mandatory for all medicinal products that have been granted a marketing authorisation. Likewise, the manufacture of investigational medicinal products must be in accordance with GMP. Advanced therapy medicinal products that are administered to patients under Article 3 of Directive 2001/83/EC (so called “hospital exemption”) must be manufactured under equivalent quality standards to the manufacturing of advanced therapy medicinal products with a marketing authorisation.
Article 5 of Regulation (EC) No 1394/2007 mandates the Commission to draw up guidelines on good manufacturing practice specific to advanced therapy medicinal products ("ATMPs"). Article 63(1) of Regulation (EU) No 536/2014 also empowers the Commission to adopt and publish detailed guidelines on good manufacturing practice applicable to investigational medicinal products.
EC 22.11.2017
EudraLex 22.11.2017
ID 16418 | 18.04.2022 / In allegato documento FAQ completo
Raccolta di tutte le FAQ REACH - Helpdesk Servizio nazionale di assistenza a...
ID 20813 | 21.11.2023
Forum project report: Harmonised enforcement project on biocidal products with approved/non-approved active substances
Helsinki...
Regolamento (UE) 2021/2045 della Commissione del 23 novembre 2021 che modifica l’allegato XIV del...
Testata editoriale iscritta al n. 22/2024 del registro periodici della cancelleria del Tribunale di Perugia in data 19.11.2024